• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期非小细胞肺癌的手术治疗存在性别差异。

Sex differences persist across surgical treatments in early-stage non-small cell lung cancer.

作者信息

Copeland Jessica, Farooq Tayyiaba, Phillips Sophia, Blehm Taelyr, Drew Grace, Orav Endel

机构信息

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Mass.

Rowan-Virtua School of Osteopathic Medicine, Stratford, NJ.

出版信息

JTCVS Open. 2025 Apr 10;25:406-414. doi: 10.1016/j.xjon.2025.03.022. eCollection 2025 Jun.

DOI:10.1016/j.xjon.2025.03.022
PMID:40631006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12230562/
Abstract

OBJECTIVE

Sex-based overall survival in patients with early-stage non-small cell lung cancer who undergo surgery is not well characterized. Existing data are limited by small sample sizes and underrepresentation of female patients or do not address overall survival according to surgical approach. The objective of this study was to compare overall survival among female and male patients with early-stage non-small cell lung cancer who underwent surgery.

METHODS

Data were extracted from the National Cancer Database for all patients diagnosed with clinical stage I-IIB non-small cell lung cancer who underwent surgical resection from 2009 to 2018, had R margins, and had at least 10 lymph nodes sampled for metastasis. Overall survival of the study sample was evaluated based on sex using multivariable Cox proportional hazards modeling and propensity score-matched analysis.

RESULTS

Of the 79,209 patients included in the study sample, 43,218 (54.6%) were female. A propensity score-matched analysis of 23,988 female and 23,988 male patients with early-stage non-small cell lung cancer who underwent surgery showed that the female group had significantly improved 5-year overall survival at 71.2% (95% CI, 70.5-71.8) compared with the male group at 61.7% (95% CI, 61.0-62.4) (log-rank, < .0001).

CONCLUSIONS

Female patients with early-stage non-small cell lung cancer who underwent surgery had significantly better overall survival at 5 years when compared with their male counterparts.

摘要

目的

接受手术治疗的早期非小细胞肺癌患者的性别相关总生存率尚未得到充分描述。现有数据受样本量小和女性患者代表性不足的限制,或者未根据手术方式探讨总生存率。本研究的目的是比较接受手术治疗的早期非小细胞肺癌女性和男性患者的总生存率。

方法

从国家癌症数据库中提取2009年至2018年期间诊断为临床I-IIB期非小细胞肺癌、接受手术切除、切缘阴性且至少采集10个淋巴结用于转移检测的所有患者的数据。使用多变量Cox比例风险模型和倾向评分匹配分析,根据性别评估研究样本的总生存率。

结果

研究样本中的79209例患者中,43218例(54.6%)为女性。对23988例接受手术的早期非小细胞肺癌女性患者和23988例男性患者进行倾向评分匹配分析,结果显示女性组5年总生存率显著提高,为71.2%(95%CI,70.5-71.8),而男性组为61.7%(95%CI,61.0-62.4)(对数秩检验,P<0.0001)。

结论

接受手术治疗的早期非小细胞肺癌女性患者的5年总生存率显著高于男性患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad20/12230562/485b6501d500/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad20/12230562/dcc97ac6d384/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad20/12230562/ae43604e4ce1/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad20/12230562/411c8567c727/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad20/12230562/56678844c16d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad20/12230562/485b6501d500/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad20/12230562/dcc97ac6d384/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad20/12230562/ae43604e4ce1/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad20/12230562/411c8567c727/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad20/12230562/56678844c16d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad20/12230562/485b6501d500/gr3.jpg

相似文献

1
Sex differences persist across surgical treatments in early-stage non-small cell lung cancer.早期非小细胞肺癌的手术治疗存在性别差异。
JTCVS Open. 2025 Apr 10;25:406-414. doi: 10.1016/j.xjon.2025.03.022. eCollection 2025 Jun.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Surgery for limited-stage small-cell lung cancer.局限期小细胞肺癌的手术治疗
Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD011917. doi: 10.1002/14651858.CD011917.pub2.

本文引用的文献

1
Lung cancer in females-sex-based differences from males in epidemiology, biology, and outcomes: a narrative review.女性肺癌——在流行病学、生物学及预后方面与男性的性别差异:一篇综述
Transl Lung Cancer Res. 2024 Jan 31;13(1):163-178. doi: 10.21037/tlcr-23-744. Epub 2024 Jan 29.
2
Sex disparities in lung cancer survival rates based on screening status.基于筛查状况的肺癌生存率中的性别差异。
Lung Cancer. 2022 Sep;171:115-120. doi: 10.1016/j.lungcan.2022.07.015. Epub 2022 Aug 1.
3
Gender medicine and oncology: report and consensus of an ESMO workshop.
性别医学与肿瘤学:ESMO 研讨会报告与共识。
Ann Oncol. 2019 Dec 1;30(12):1914-1924. doi: 10.1093/annonc/mdz414.
4
Global Epidemiology of Lung Cancer.全球肺癌流行病学。
Ann Glob Health. 2019 Jan 22;85(1):8. doi: 10.5334/aogh.2419.
5
Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis.吸烟作为男性和女性肺癌的危险因素:一项系统评价和荟萃分析。
BMJ Open. 2018 Oct 3;8(10):e021611. doi: 10.1136/bmjopen-2018-021611.
6
Gender Differences in the Recurrence Timing of Patients Undergoing Resection for Non-Small Cell Lung Cancer.接受非小细胞肺癌切除术患者复发时间的性别差异
Asian Pac J Cancer Prev. 2018 Mar 27;19(3):719-724. doi: 10.22034/APJCP.2018.19.3.719.
7
Sex differences in lung cancer survival: long-term trends using population-based cancer registry data in Osaka, Japan.肺癌生存率的性别差异:利用日本大阪基于人群的癌症登记数据的长期趋势
Jpn J Clin Oncol. 2017 Sep 1;47(9):863-869. doi: 10.1093/jjco/hyx094.
8
Sex differences in early outcomes after lung cancer resection: analysis of the Society of Thoracic Surgeons General Thoracic Database.肺癌切除术后早期结局的性别差异:胸外科医师学会普通胸科数据库分析。
J Thorac Cardiovasc Surg. 2014 Jul;148(1):13-8. doi: 10.1016/j.jtcvs.2014.03.012. Epub 2014 Mar 14.
9
Sex and gender differences in non-small cell lung cancer.非小细胞肺癌中的性别差异。
Semin Thorac Cardiovasc Surg. 2011 Summer;23(2):137-45. doi: 10.1053/j.semtcvs.2011.07.001.
10
Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis.女性性别是非小细胞肺癌的独立预后因素:一项荟萃分析。
Ann Thorac Cardiovasc Surg. 2011;17(5):469-80. doi: 10.5761/atcs.oa.10.01637. Epub 2011 Jul 27.